Document:

2011 Bonus Plan

 Exhibit 10.21 
 RIB-X PHARMACEUTICALS, INC. 
 2011 BONUS PLAN 

(As Amended April 20, 2012) 
 Section 1. PURPOSE 
 The Plan is intended
to incentivize the Company’s employees to increase the value and attractiveness of the Company with the goal of achieving a transaction which is either a Sale Event or a Non-Sale Event by providing these individuals an incentive payment tied to
the accomplishment of this goal. 
 Section 2. DEFINITIONS 

(a) “Administrator” shall mean the Compensation Committee of the Board unless, at the discretion of the Board, another
committee of the Board is appointed to administer the Plan or the Board determines to administer the Plan itself. 
 (b)
“Board” shall mean the Board of Directors of the Company. 
 (c) “Bonus Pool” shall be an
amount available for distribution under this Plan as calculated pursuant to Section 4. 
 (d) “Bonus
Amount” shall mean, for any Participant, the amount payable to such Participant in connection with a Triggering Event. 

(e) “Cause” shall, with respect to any Participant, have the meaning ascribed to it in such Participant’s
employment agreement with the Company, or if such Participant does not have such an employment agreement or the employment agreement does not contain a definition of “Cause” then “Cause” shall mean that such Participant:
(i) willfully failed to follow lawful, written directions communicated to him by the Board of Directors or the Chief Executive Officer of the Company (or their respective designees); (ii) willfully engaged in conduct which is materially
injurious to the Company, monetarily or otherwise; (iii) acted with material dishonesty or materially breached any fiduciary duty owed to the Company; (iv) was convicted of, pleaded guilty to or confessed to an act of fraud,
misappropriation or embezzlement or to any felony; (v) used illegal substances at any time; or (vi) materially breached this Agreement or the Participant’s non-disclosure and developments (or similar) agreement with the Company,
provided that the Company first notified such Participant in writing of the acts or omissions constituting Cause under (i), (ii), (iii) or (vi) and such Participant failed to cure such acts or omissions (if curable) within thirty
(30) days of receiving the Company’s notice. Any determination of the existence of Cause will be made by the Administrator whose ruling shall be final. 
 (f) “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time. 

  

 (g) “Company” shall mean Rib-X Pharmaceuticals, Inc., a Delaware
corporation. 
 (h) “Company Voting Securities” shall mean the voting securities of the Company entitled to
vote generally in the election of directors, determined on a fully diluted, as-converted to common stock basis. 
 (i)
“Current Stockholders” shall mean the beneficial owners (within the meaning of Rule 13d-3 promulgated under the Securities Exchange Act of 1934) of the Company Voting Securities and their affiliates as of the Effective Date.

 (j) “Effective Date” shall mean August 2, 2011. 

(k) “Eligible Individual” shall mean each active employee of the Company or its subsidiaries. 

(l) “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time. 

(m) “Good Reason” shall, with respect to any Participant, have the meaning ascribed to it in such Participant’s
employment agreement with the Company, or if such Participant does not have such an employment agreement or the employment agreement does not contain a definition of “Good Reason” then “Good Reason” shall mean that the Company:
(i) materially diminished such Participant’s base salary; (ii) materially diminished such Participant’s authority, duties or responsibilities; (iii) required such Participant to relocate permanently to an office more than
fifty (50) miles from New Haven, Connecticut without such Participant’s consent; or (iv) materially breached the terms of any agreement between such Participant and the Company, provided that with respect to (i), (ii), (iii), or (iv),
such Participant’s resignation for Good Reason will only become effective if the Company fails to cure the acts or omissions giving rise to a resignation of such Participant’s employment for Good Reason with thirty (30) days of
receiving written notice from such Participant stating his intent to resign his employment for Good Reason and specifying the Company’s acts or omissions under the applicable provision giving rise to a resignation of his employment for Good
Reason. Such Participant must provide this notice to the Company within ninety (90) days of the date the acts or omissions giving rise to a resignation of such Participant’s employment for Good Reason first arise. 

(n) “Initial Public Offering” shall mean the first underwritten public offering of Company Voting Securities offered on
a firm commitment basis pursuant to an effective registration statement filed with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, on Form S-1 or its then equivalent. 

(o) “Intrinsic Stock Option Value” shall mean, for a Participant in connection with a Triggering Event, the aggregate
amount by which (i) the value of all Company Voting Securities issued, or then issuable, to the Participant pursuant to outstanding vested Company stock options (including options exercised in connection with the Triggering Event) exceeds
(ii) the aggregate exercise price of all such Company stock options. 

  
 2 

 (p) “Non-Sale Event” shall mean the first to occur of an Initial Public
Offering or a Reverse Merger. 
 (q) “Participant” shall mean those Eligible Individuals determined by the
Administrator. 
 (r) “Participant Percentage” shall mean, for each Participant, the percentage of the Bonus
Pool to which such Participant may become entitled in accordance with the terms of the Plan, as awarded by the Administrator pursuant to Section 4 below. 
 (s) “Plan” shall mean this Rib-X Pharmaceuticals, Inc. 2011 Bonus Plan, as amended. 
 (t) “Pre-Money Valuation” shall mean 
 (i) in the
event of an Initial Public Offering, the number of shares of Company Voting Securities immediately prior to the consummation of the Initial Public Offering multiplied by the initial price per share to the public as set forth in the
effective registration statement filed with the Securities and Exchange Commission; and 
 (ii) in the event of a
Reverse Merger, the number of shares of the resulting or acquiring corporation stock issued to the holders of the Company, adjusted to reflect shares that may become issuable upon the exercise of options, multiplied by the market price
of the acquirer common stock on the closing date of the Reverse Merger. 
 (u) “Reverse Merger” shall mean the
consummation of a merger or share exchange involving the Company as the result of which the equity of the Company (including outstanding warrants and stock options) is converted into the ownership of (or the right to receive upon exercise) at least
50% of the equity of the resulting or acquiring corporation which resulting or acquiring corporation is then traded on a major international stock exchange including but not limited to NYSE, NASDAQ, AMEX or LSE. 

(v) “RSU” shall mean any restricted stock unit granted pursuant to the terms of the Plan. 

(w) “Sale Proceeds” shall mean the consideration received by the Company or its stockholders upon a Sale Event; net, in
the case of a Sale Event under clause (ii) of the definition of “Sale Event”, of retained liabilities (excluding any liabilities under this Plan or any similar plan providing compensation to members of the Board in connection with
Sale Events and/or Non-Sale Events, and any liabilities to Company stockholders or their affiliates in respect of promissory notes issued by the Company) required to be disclosed on the Company’s balance sheet or financial statements prepared
immediately following the consummation thereof in accordance with generally acceptable accounting principles applied consistently by the Company. For purposes of determining Sale Proceeds upon the occurrence of a Sale Event, to the extent that
(i) any consideration otherwise receivable by the Company or its stockholders is 

  
 3 

 
deposited in escrow, or otherwise receivable as a non-contingent deferred payment, such amount shall be included in Sale Proceeds, and (ii) any portion of the consideration is payable to the
Company or its stockholders as a contingent deferred payment (an “Earn-Out Amount”), such amount shall be excluded from Sale Proceeds until such amount is actually paid to the Company or its stockholders. 

(x) “Sale Event” shall mean: 
 (i) the consummation of a sale, merger, consolidation, or series of related events following which the Current Stockholders beneficially own (within the meaning of Rule 13d-3 promulgated under the
Securities Exchange Act of 1934) securities representing less than fifty percent (50%) of the voting power of the Company Voting Securities; provided, however, that such event shall not constitute a Sale Event hereunder if the
Current Stockholders retain directly or through ownership of one or more holding companies, immediately following such event, a majority of the voting securities entitled to vote generally in the election of directors of the successor entity; or

 (ii) the consummation of a sale or other disposition of all or substantially all of the assets of the Company. 

(y) “Target Bonus Amount” shall mean, for a Participant in connection with a Triggering Event, an amount equal to the
amount of the Bonus Pool for such Triggering Event multiplied by such Participant’s Participant Percentage. 

(z) “Triggering Event” shall mean the first Sale Event or Non-Sale Event to occur during the term of this Plan in which
the Triggering Event Valuation equals or exceeds $52.5 million. 
 (aa) “Triggering Event Per Share Valuation”
shall mean the Triggering Event Valuation divided by the number of shares of Company Voting Securities. 
 (bb)
“Triggering Event Valuation” shall mean, for a Sale Event the Sale Proceeds and for a Non-Sale Event the Pre-Money Valuation of the Company implied by the Non-Sale Event. 

Section 3. ADMINISTRATION 

The Plan shall be administered by the Administrator, and the Administrator will (i) construe, interpret, and implement the Plan,
(ii) prescribe, amend, and rescind rules and regulations relating to the Plan, and (iii) make all other determinations deemed necessary or advisable for the administration of the Plan. The determination of the Administrator on all matters
relating to the Plan or any amounts payable hereunder shall be final, binding, and conclusive. 

  
 4 

 Section 4. PARTICIPATION PERCENTAGE,
BONUS POOL AND BONUS AMOUNTS 
 (a)
The Administrator shall determine which Eligible Individuals shall be Participants and shall award each Participant a Participant Percentage. It is the intent of this Plan that the aggregate Participant Percentages of all Participants shall equal
100%. A Participant’s Participant Percentage may be increased by a subsequent award, but may not be decreased without the consent of the Participant. 
 (b) On or prior to the date of a Triggering Event, the Administrator shall determine the Bonus Pool calculated as 10% of that portion of the Triggering Event Valuation above $52.5 million. 

(c) In connection with a Triggering Event, each Participant’s Bonus Amount shall be equal to the amount, if any, by which
(y) the Participant’s Target Bonus Amount for such Triggering Event exceeds (z) the Participant’s Intrinsic Stock Option Value as of the date of such Triggering Event. 

(d) Any portion of the Bonus Pool that is not payable as Bonus Amounts hereunder shall be retained by the Company. 

Section 5. PAYMENT OF BONUS AMOUNTS 

(a) Upon the occurrence of a Sale Event or a Non-Sale Event, the Administrator shall, in good faith, determine whether such transaction
constitutes a Triggering Event. If the Sale Event or Non-Sale Event is a Triggering Event, each Participant shall be paid his or her Bonus Amount on or promptly following the Triggering Event, and in no event later than sixty (60) days
following the Triggering Event. To the extent that an Earn-Out Amount may be payable in connection with a Sale Event or Non-Sale Event, upon receipt by the Company or its stockholders of any Earn-Out Amount (each such date of receipt of such
consideration being, a “Recalculation Date”), the Triggering Event Valuation shall be recalculated using the aggregate Sale Proceeds received through and including such Recalculation Date or the Pre-Money Valuation as adjusted to
reflect the Earn-Out Amount, as applicable. The Administrator shall determine whether, as of any Recalculation Date, a Triggering Event has occurred (if it had not previously) and what the Bonus Pool and each Participant’s Bonus Amount would be
for such Triggering Event after recalculating the Triggering Event Valuation. On or promptly following such Recalculation Date, and in no event later than sixty (60) days following the Recalculation Date, the Company shall pay to each
Participant the difference, if any, between any Bonus Amount previously paid to such Participant and the Bonus Amount due such Participant as recalculated. 
 (b) In the event of a Sale Event, the Bonus Amount shall be paid in the form of cash, securities, other consideration or any combination thereof as determined by the Administrator, in its sole discretion,
to parallel the type of consideration received by the Company or its Shareholders. 

  
 5 

 (c) In the event of a Non-Sale Event, the Bonus Amount shall be paid in the form of RSUs
granted to the Participant that upon vesting will require the Company to issue common stock of the Company (or securities in the resulting or acquiring company in a Reverse Merger). The number of shares subject to such RSU granted to a Participant
shall be calculated by dividing the Bonus Amount for such Participant by the Triggering Event Per Share Valuation and rounding down to the nearest whole share. Subject to a Participant’s continuous employment through the
applicable vesting dates, such Participant’s RSUs will vest as follows (i) 50% of such Participant’s grant of RSUs shall vest on the first anniversary of the Triggering Event and (ii) the remainder of each grant of RSUs will vest
pro rata on a quarterly basis over the next three years. In addition, each RSU will vest in full upon a merger, reorganization or other consolidation of the Company, including the sale of substantially all of the Company’s assets, in which the
Company is not the surviving entity and in which the persons holding the Company’s outstanding equity immediately prior to the transaction own less than 50% of the surviving entity’s total voting power immediately after the transaction,
subject to the Participant’s continuous employment through the date of such merger, reorganization or other consolidation of the Company. For the avoidance of doubt, the sale by a Current Stockholder of all or any portion of its Company Voting
Securities to a third party that results in the Current Stockholder (or all Current Stockholders) beneficially owning less than 50% of the Company’s total voting power will not result in the accelerated vesting pursuant to the previous
sentence. In the case of a Reverse Merger in which the Triggering Event Valuation is less than the enterprise value of the constituent entities to the Reverse Merger other than the Company, the vesting of the RSUs would also be subject to full
acceleration if the Participant’s employment with the Company is terminated by the Company other than for Cause, or by the Participant for Good Reason, prior to the first anniversary of the Reverse Merger. 

Section 6. TERMINATION OF EMPLOYMENT 

(a) In the event that a Participant’s employment with the Company is terminated (i) by the Company for Cause, (ii) by the
Company other than for Cause more than six months prior to the earlier to occur of a Triggering Event or the Company entering into a binding agreement with respect to a Triggering Event, or (iii) by the Participant other than for Good Reason,
prior to a Triggering Event, such Participant shall forfeit all rights to receive his or her Bonus Amount upon any subsequent Sale Event or Non-Sale Event, and shall thereafter be excluded from participation in the Plan. 

(b) Upon any termination of employment for any reason, other than for Cause, on or following a Sale Event or Non-Sale Event, a
Participant shall be entitled to receive his or her entire Bonus Amount when otherwise payable hereunder as if no termination of employment had occurred even if such Sale Event or Non-Sale Event is not determined to be a Triggering Event until after
such termination. Upon a Participant’s termination of employment for Cause on or following a Sale Event or Non-Sale Event, such Participant shall forfeit all rights to receive any further payment of his or her Bonus Amount and shall thereafter
be excluded from participation in the Plan. 

  
 6 

 Section 7. CHANGE IN CONTROL
PAYMENTS 
 (a) In the event that (A) any payment or benefit received or to be received by
the Participant in connection with a Triggering Event (whether pursuant to the terms of the Plan or any other plan, arrangement, or agreement with the Company, any person whose actions result in a Sale Event, or any person affiliated with the
Company or such person) (collectively “Parachute Payments”) would not be deductible by the Company, an affiliate or other person making such payment or providing such benefit (in whole or part) as a result of Section 280G of
the Code; and (B) it is determined in good faith by the Administrator that the net after-tax amount of the Parachute Payments retained by the Participant after deduction for any excise tax imposed by Section 4999 of the Code and any
federal, state, and local income and employment taxes would not exceed the net after-tax amount of the Parachute Payments retained by the Participant after limiting the Parachute Payments to an amount that is 2.99 times the Participant’s
“base amount” (as such term is defined by Section 280G of the Code), then the Parachute Payments shall be reduced until no portion of the Parachute Payments is not deductible. 

(b) For purposes of this provision, 
 (i) no portion of the Parachute Payments the receipt or enjoyment of which the Participant shall have effectively waived in writing prior to the date of payment of the Parachute Payments shall be taken
into account; 
 (ii) no portion of the Parachute Payments shall be taken into account which in the opinion of the
Company’s independent auditors or tax counsel serving as such immediately prior to the Triggering Event (or other tax counsel selected by the Administrator) does not constitute a “parachute payment” within the meaning of
Section 280G(b)(2) of the Code; 
 (iii) the Parachute Payments shall be reduced only to the extent necessary so that the
Parachute Payments (other than those referred to in the immediately preceding clause (i) or (ii)) in their entirety constitute reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code or
are otherwise not subject to disallowance as deductions, in the opinion of the auditor or tax counsel referred to in such clause (ii); and 
 (iv) the value of any non-cash benefit or any deferred payment or benefit included in the Parachute Payments shall be determined by the Company’s independent auditors or tax counsel based on Sections
280G and 4999 of the Code and the regulations for applying those Code Sections, or on substantial authority within the meaning of Section 6662 of the Code. 
 (c) In addition, if any portion of the Parachute Payments is determined not to be deductible by reason of Section 280G of the Code, then, to the extent reasonably practicable and permitted by
applicable law, the Company and the Participant shall use all commercially reasonable efforts to obtain stockholder approval in accordance with Section 280G of the Code with respect to any payments or benefits that the Participant elects to
waive and subject the Participant’s right to receive the same to approval thereof by the stockholders of the Company. 

  
 7 

 Section 8. NON-ALIENATION OF
BENEFITS 
 A Participant may not assign, sell, encumber, transfer, or otherwise dispose of any
rights or interests under the Plan except by will or the laws of descent and distribution. Any attempted disposition in contravention of the preceding sentence shall be null and void. 

Section 9. NO CLAIM OF RIGHT UNDER THE
PLAN 
 Neither the Plan nor any action taken pursuant to the Plan shall be construed as giving
any Participant any right to be retained in the employ of the Company. 
 Section 10.
TAXES 
 The Company shall deduct from all amounts paid to the Participant under the Plan
all federal, state, local, and other taxes required by law to be withheld with respect to such payments. In the event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act (“F.I.C.A.”)
withholdings or other amounts are required by applicable law or governmental regulation to be withheld from the Participant’s salary, wages or other remuneration in connection with the issuance of an RSU under the Plan or for any other reason
required by law, the Company may withhold from the Participant’s compensation, if any, or may require that the Participant advance in cash to the Company, or to any affiliate of the Company which employs or employed the Participant, the
statutory minimum amount of such withholdings unless a different withholding arrangement is authorized by the Administrator (and permitted by law). 
 Section 11. NO LIABILITY OF ADMINISTRATOR 
 Neither the Administrator nor its members shall be personally liable by reason of any contract or other instrument related to the Plan executed by an individual or on its or their behalf in its or their
capacity as the Administrator (or members thereof), or for any mistake of judgment made in good faith, and the Company shall indemnify and hold harmless each individual to whom any duty or power relating to the administration or interpretation of
the Plan may be allocated or delegated, against any cost or expense (including legal fees) or liability arising out of any act or omission to act in connection with the Plan unless arising out of such person’s own fraud or bad faith.

 Section 12. AMENDMENT AND TERMINATION OF
THE PLAN 
 The Plan shall terminate on June 30, 2012, without further
action by the Board or the Administrator; provided however that the Administrator will determine by March 31, 2012 whether or not this Plan shall be extended. Notwithstanding the foregoing, if at any time the Company completes any debt or
equity financing after the Effective Date the Administrator may in its sole discretion modify this Plan and the Triggering Event Valuation equitably to reflect the implications of such financing. 

  
 8 

 Section 13. SECTION 409A 

The payments under this Plan are intended to be exempt from Section 409A of the Code pursuant to Treas. Reg. §1.409A-1(a)(b)(4)
(the “short term deferral” exemption), and will be administered accordingly. Notwithstanding the foregoing, in no event whatsoever shall the Company or any of its affiliates be liable for any additional tax, interest, or penalties that may
be imposed on any Participant by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code, other than for withholding obligations or other obligations applicable to employers, if any, under
Section 409A of the Code. 
 Section 14. UNFUNDED PLAN 

(a) Participants shall have no right, title, or interest whatsoever in or to any investments which the Company may make to aid it in
meeting its obligations under the Plan. Notwithstanding anything contained herein to the contrary, to the extent that any person acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of
an unsecured general creditor of the Company. 
 (b) The Plan is intended to be a “bonus plan” which is not subject to
the ERISA. If the Plan is nonetheless determined to be so subject, it is intended to constitute a “plan which is unfunded and is maintained by the employer primarily for the purpose of providing deferred compensation for a select group of
management or highly compensated employees,” as such phrase is used in ERISA, and the terms of the Plan shall be interpreted consistent with such intent. 
 Section 15. SUCCESSORS 
 As a condition
to the consummation of a sale, merger, or consolidation of the Company, in addition to any obligations imposed by law upon any successor to the Company, the Company shall require any successor (whether direct or indirect, by purchase of stock or
assets, merger, consolidation, or otherwise) to all or substantially all of the business or assets the Company to expressly assume the Plan and agree to perform obligations hereunder in the same manner and to the same extent that the Company would
be required to perform it if no such succession had taken place. 
 Section 16. GOVERNING
LAW 
 The terms of the Plan and all rights thereunder shall be governed by and construed in
accordance with the laws of the State of Delaware, without reference to principles of conflict of laws. 

*    *    * 

  
 92012 Employee Stock Purchase Plan

 Exhibit 10.48 
 RIB-X PHARMACEUTICALS, INC. 
 2012 EMPLOYEE STOCK PURCHASE PLAN

 The following constitute the provisions of the 2012 Employee Stock Purchase Plan (the “Plan”) of Rib-X
Pharmaceuticals, Inc. (the “Company”). 
 1. Purpose. The purpose of the Plan is to provide Employees of the
Company and its Designated Subsidiaries with an opportunity to purchase Common Stock of the Company. It is the intention of the Company to have the Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Code. The
provisions of the Plan shall, accordingly, be construed so as to extend and limit participation in a manner consistent with the requirements of that section of the Code. 
 2. Definitions. 
 (a) “Board” shall mean the Board of
Directors of the Company, or a committee of the Board of Directors named by the Board to administer the Plan. 
 (b)
“Code” shall mean the Internal Revenue Code of 1986, as amended. 
 (c) “Common Stock” shall
mean the common stock, $.001 par value per share, of the Company. 
 (d) “Company” shall mean Rib-X
Pharmaceuticals, Inc., a Delaware corporation. 
 (e) “Compensation” shall mean total cash compensation
received by the Employee from the Company or a Designated Subsidiary that is taxable income for federal income tax purposes, including, payments for overtime, shift premium, incentive compensation, incentive payments, bonuses, commissions and other
compensation received from the Company or a Designated Subsidiary, but excluding relocation, expense reimbursements, tuition or other reimbursements and income realized as a result of participation in any stock option, stock purchase or similar plan
of the Company or a Designated Subsidiary. 
 (f) “Continuous Status as an Employee” shall mean the absence of
any interruption or termination of service as an Employee. Continuous Status as an Employee shall not be considered interrupted in the case of a leave of absence agreed to in writing by the Company, provided that such leave is for a period of not
more than 90 days or reemployment upon the expiration of such leave is guaranteed by contract or statute. 
 (g)
“Contributions” shall mean all amounts credited to the account of a participant pursuant to the Plan. 
 (h)
“Designated Subsidiaries” shall mean the Subsidiaries which have been designated by the Board from time to time in its sole discretion as eligible to participate in the Plan. 

(i) “Employee” shall mean any person who is employed by the Company or one of its Designated Subsidiaries for tax
purposes and who is customarily employed for at least 20 hours per week and more than five months in a calendar year by the Company or one of its Designated Subsidiaries. 
 (j) “Exercise Date” shall mean the last business day of each Offering Period of the Plan. 

  
 1 

 (k) “Exercise Price” shall mean with respect to an Offering Period, an
amount equal to 85% of the fair market value (as defined in paragraph 7(b)) of a share of Common Stock on the Offering Date or on the Exercise Date, whichever is lower. 
 (l) “Offering Date” shall mean the first business day of each Offering Period of the Plan. 
 (m) “Offering Period” shall mean a period of six months as set forth in paragraph 4 of the Plan. 
 (n) “Plan” shall mean this Rib-X Pharmaceuticals, Inc. 2012 Employee Stock Purchase Plan. 
 (o) “Subsidiary” shall mean a corporation, domestic or foreign, of which not less than 50% of the voting shares are held by the Company or a Subsidiary, whether or not such corporation
now exists or is hereafter organized or acquired by the Company or a Subsidiary. 
 3. Eligibility. 

(a) Any person who has been continuously employed as an Employee for three months as of the Offering Date of a given Offering Period shall
be eligible to participate in such Offering Period under the Plan and further, subject to the requirements of paragraph 5(a) and the limitations imposed by Section 423(b) of the Code. All Employees granted options under the Plan with respect to
any Offering Period will have the same rights and privileges except for any differences that may be permitted pursuant to Section 423. 
 (b) Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) if, immediately after the grant, such Employee (or any other person whose
stock would be attributed to such Employee pursuant to Section 424(d) of the Code) would own stock and/or hold outstanding options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all
classes of stock of the Company or of any Subsidiary of the Company, (ii) which permits his or her rights to purchase stock under all employee stock purchase plans (described in Section 423 of the Code) of the Company and its Subsidiaries
to accrue at a rate which exceeds $25,000 of fair market value of such stock as defined in paragraph 7(b) (determined at the time such option is granted) for each calendar year in which such option is outstanding at any time, or (iii) to
purchase in any one Offering Period more than the number of shares of Common Stock equal to fifteen percent (15%) of such Employee’s annual salary (determined as of January 1 of the year in which the Offering Period commences) divided
by the fair market value of the Common Stock on the first day of such Offering Period (subject to any adjustment pursuant to paragraph 18). Any option granted under the Plan shall be deemed to be modified to the extent necessary to satisfy this
paragraph 3(b). 
 4. Offering Periods. The Plan shall be implemented by a series of Offering Periods, with a new
Offering Period commencing on January 1 and July 1 of each year or the first business day thereafter (or at such other time or times as may be determined by the Board). The initial Offering Period shall commence on such date as determined
by the Board. 
 5. Participation. 
 (a) An eligible Employee may become a participant in the Plan by completing an Enrollment Form provided by the Company and filing it with the Company or its designee prior to the applicable Offering Date,
unless a later time for filing the Enrollment Form is set by the Board for all eligible Employees with respect to a given Offering Period. The Enrollment Form and its submission may be 

  
 2 

 
electronic as directed by the Company. The Enrollment Form shall set forth the percentage of the participant’s Compensation (which shall be not less than 1% and not more than 10%) to be paid
as Contributions pursuant to the Plan. 
 (b) Payroll deductions shall commence with the first payroll following the Offering
Date, unless a later time is set by the Board with respect to a given Offering Period, and shall end on the last payroll paid on or prior to the Exercise Date of the Offering Period to which the Enrollment Form is applicable, unless sooner
terminated as provided in paragraph 10. 
 6. Method of Payment of Contributions. 

(a) Each participant shall elect to have payroll deductions made on each payroll during the Offering Period in an amount not less than 1%
and not more than 10% of such participant’s Compensation on each such payroll; provided that the aggregate of such payroll deductions during the Offering Period shall not exceed 10% of the participant’s aggregate Compensation during said
Offering Period (or such other percentage as the Board may establish from time to time before an Offering Date). All payroll deductions made by a participant shall be credited to his or her account under the Plan. A participant may not make any
additional payments into such account. 
 (b) A participant may discontinue his or her participation in the Plan as provided in
paragraph 10, or, on one occasion only during the Offering Period, may decrease, but may not increase, the rate of his or her Contributions during the Offering Period by completing and filing with the Company a new Enrollment Form authorizing a
change in the deduction rate. The change in rate shall be effective as of the beginning of the next payroll period following the date of filing of the new Enrollment Form, if the Enrollment Form is completed at least ten business days prior to such
date, and, if not, as of the beginning of the next succeeding payroll period. 
 (c) Notwithstanding the foregoing, to the
extent necessary to comply with Section 423(b)(8) of the Code and paragraph 3(b), a participant’s payroll deductions may be decreased to 0% at such time during any Offering Period which is scheduled to end during the current calendar year
that the aggregate of all payroll deductions accumulated with respect to such Offering Period and any other Offering Period ending within the same calendar year equals $21,250. Payroll deductions shall recommence at the rate provided in such
participant’s Enrollment Form at the beginning of the first Offering Period which is scheduled to end in the following calendar year, unless terminated by the participant as provided in paragraph 10. 

7. Grant of Option. 
 (a) On the Offering Date of each Offering Period, each eligible Employee participating in such Offering Period shall be granted an option to purchase on the Exercise Date of such Offering Period a number
of shares of the Common Stock determined by dividing such Employee’s Contributions accumulated prior to such Exercise Date and retained in the participant’s account as of the Exercise Date by the applicable Exercise Price; provided
however, that such purchase shall be subject to the limitations set forth in paragraphs 3(b) and 12. The fair market value of a share of the Common Stock shall be determined as provided in paragraph 7(b). 

(b) The fair market value of the Common Stock on a given date shall be (i) if the Common Stock is listed on a national securities
exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or last sale price of the Common Stock for such date (or, in the event that the Common Stock is not traded on such date, on
the immediately preceding trading date), on the composite tape or other comparable reporting system; or (ii) if the Common Stock is 

  
 3 

 
not listed on a national securities exchange and such price is not regularly reported, the mean between the bid and asked prices per share of the Common Stock at the close of trading in the
over-the-counter market. 
 8. Exercise of Option. Unless a participant withdraws from the Plan as provided in paragraph
10, his or her option for the purchase of shares will be exercised automatically on the Exercise Date of the Offering Period, and the maximum number of full shares subject to the option will be purchased for him or her at the applicable Exercise
Price with the accumulated Contributions in his or her account. If a fractional number of shares results, then such number shall be rounded down to the next whole number and any unapplied cash shall be carried forward to the next Exercise Date,
unless the participant requests a cash payment. The shares purchased upon exercise of an option hereunder shall be deemed to be transferred to the participant on the Exercise Date. During a participant’s lifetime, a participant’s option to
purchase shares hereunder is exercisable only by him or her. 
 9. Delivery. Upon the written request of a participant,
certificates representing the shares purchased upon exercise of an option will be issued as promptly as practicable after the Exercise Date of each Offering Period to participants who wish to hold their shares in certificate form, except that the
Board may determine that such shares shall be held for each participant’s benefit by a broker designated by the Board. Any payroll deductions accumulated in a participant’s account which are not sufficient to purchase a full Share shall be
retained in the participant’s account for the subsequent Offering Period, subject to earlier withdrawal by the participant as provided in paragraph 10 below. Any other amounts left over in a participant’s account after an Exercise Date
shall be returned to the participant. 
 10. Withdrawal; Termination of Employment. 

(a) A participant may withdraw all but not less than all the Contributions credited to his or her account under the Plan at any time prior
to the Exercise Date of the Offering Period by giving written notice to the Company or its designee. All of the participant’s Contributions credited to his or her account will be paid to him or her promptly after receipt of his or her notice of
withdrawal and his or her option for the current period will be automatically terminated, and no further Contributions for the purchase of shares will be made during the Offering Period. 

(b) Upon termination of the participant’s Continuous Status as an Employee prior to the Exercise Date of the Offering Period for any
reason, including retirement or death, the Contributions credited to his or her account will be returned to him or her or, in the case of his or her death, to the person or persons entitled thereto under paragraph 14, and his or her option will be
automatically terminated. 
 (c) In the event an Employee fails to remain in Continuous Status as an Employee for at least 20
hours per week during the Offering Period in which the Employee is a participant, he or she will be deemed to have elected to withdraw from the Plan and the Contributions credited to his or her account will be returned to him or her and his or her
option terminated. 
 (d) A participant’s withdrawal from an Offering Period will not have any effect upon his or her
eligibility to participate in a succeeding offering or in any similar plan which may hereafter be adopted by the Company. 
 11.
Interest. No interest shall accrue on the Contributions of a participant in the Plan. 

  
 4 

 12. Stock. 
 (a) The maximum number of shares of Common Stock which shall be made available for sale under the Plan shall be 907,305,600 shares, plus an annual increase on the first day of each of the Company’s
fiscal years beginning in 2013, equal to the lesser of (i) 907,305,600 shares, (ii) 1% of the shares of Common Stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as is
determined by the Board, subject to adjustment upon changes in capitalization of the Company as provided in paragraph 18. If the total number of shares which would otherwise be subject to options granted pursuant to paragraph 7(a) on the Offering
Date of an Offering Period exceeds the number of shares then available under the Plan (after deduction of all shares for which options have been exercised), the Company shall make a pro rata allocation of the shares remaining available for option
grants in as uniform a manner as shall be practicable and as it shall determine to be equitable. Any amounts remaining in an Employee’s account not applied to the purchase of shares pursuant to this paragraph 12 shall be refunded on or promptly
after the Exercise Date. In such event, the Company shall give written notice of such reduction of the number of shares subject to the option to each Employee affected thereby and shall similarly reduce the rate of Contributions, if necessary.

 (b) The participant will have no interest or voting right in shares covered by his or her option until such option has been
exercised. 
 13. Administration. The Board shall supervise and administer the Plan and shall have full power to adopt,
amend and rescind any rules deemed desirable and appropriate for the administration of the Plan and not inconsistent with the Plan, to construe and interpret the Plan, and to make all other determinations necessary or advisable for the
administration of the Plan. 
 14. Designation of Beneficiary. 

(a) A participant may designate a beneficiary who is to receive any shares and cash, if any, from the participant’s account under the
Plan in the event of such participant’s death subsequent to the end of the Offering Period but prior to delivery to him or her of such shares and cash. In addition, a participant may designate a beneficiary who is to receive any cash from the
participant’s account under the Plan in the event of such participant’s death prior to the Exercise Date of the Offering Period. If a participant is married and the designated beneficiary is not the spouse, spousal consent shall be
required for such designation to be effective. Beneficiary designations shall be made either in writing or by electronic delivery as directed by the Company. 
 (b) Such designation of beneficiary may be changed by the participant (and his or her spouse, if any) at any time by submission of the required notice, which may be electronic. In the event of the death
of a participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of
the participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or relatives of the
participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. 
 15. Transferability. Neither Contributions credited to a participant’s account nor any rights with regard to the exercise of an option or to receive shares under the Plan may be assigned,
transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in paragraph 14) by the participant. Any such attempt at assignment, transfer, pledge or other disposition shall be
without effect, except that the Company may treat such act as an election to withdraw funds in accordance with paragraph 10. 

  
 5 

 16. Use of Funds. All Contributions received or held by the Company under the Plan
may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such Contributions. 

17. Reports. Individual accounts will be maintained for each participant in the Plan. Statements of account will be given to
participating Employees promptly following the Exercise Date, which statements will set forth the amounts of Contributions, the per share purchase price, the number of shares purchased and the remaining cash balance, if any. 

18. Adjustments Upon Changes in Capitalization. Subject to any required action by the stockholders of the Company, the number of
shares of Common Stock covered by unexercised options under the Plan and the number of shares of Common Stock which have been authorized for issuance under the Plan but are not yet subject to options under paragraph 12(a), the number of shares of
Common Stock set forth in paragraph 12(a)(i), (collectively, the “Reserves”), the maximum number of shares of Common Stock that may be purchased by a participant in an Offering Period set forth in paragraph 3(b), as well as the price per
share of Common Stock covered by each unexercised option under the Plan, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Common Stock. Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. 
 In the event of the proposed dissolution or liquidation of the Company, an Offering Period then in progress will terminate immediately prior to the consummation of such proposed action, unless otherwise
provided by the Board. In the event of a proposed sale of all or substantially all of the assets of the Company, or the merger, consolidation or other capital reorganization of the Company with or into another corporation, each option outstanding
under the Plan shall be assumed or an equivalent option shall be substituted by such successor corporation or a parent or subsidiary of such successor corporation, unless the Board determines, in the exercise of its sole discretion and in lieu of
such assumption or substitution, to shorten the Offering Period then in progress by setting a new Exercise Date (the “New Exercise Date”). If the Board shortens the Offering Period then in progress in lieu of assumption or substitution in
the event of a merger or sale of assets, the Board shall notify each participant in writing, at least ten days prior to the New Exercise Date, that the Exercise Date for his or her option has been changed to the New Exercise Date and that his or her
option will be exercised automatically on the New Exercise Date, unless prior to such date he or she has withdrawn from the Offering Period as provided in paragraph 10. For purposes of this paragraph, an option granted under the Plan shall be deemed
to be assumed if, following the sale of assets, merger or other reorganization, the option confers the right to purchase, for each share of Common Stock subject to the option immediately prior to the sale of assets, merger or other reorganization,
the consideration (whether stock, cash or other securities or property) received in the sale of assets, merger or other reorganization by holders of Common Stock for each share of Common Stock held on the effective date of such transaction (and if
such holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if such consideration received in such transaction was not solely
common stock of the successor corporation or its parent (as defined in Section 424(e) of the Code), the Board may, with the consent of the successor corporation, provide for the consideration to be received upon exercise of the option to be
solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of Common Stock in the sale of assets, merger or other reorganization. 

The Board may, if it so determines in the exercise of its sole discretion, also make provision for adjusting the Reserves, as well as the
price per share of Common Stock covered by each outstanding option, in the event that the Company effects one or more reorganizations, recapitalizations, rights offerings or other increases or reductions of shares of its outstanding Common Stock,
and in the event of the Company being consolidated with or merged into any other corporation. 

  
 6 

 19. Amendment or Termination. 

(a) The Board may at any time terminate or amend the Plan. Except as provided in paragraph 18, no such termination may affect options
previously granted, nor may an amendment make any change in any option theretofore granted which adversely affects the rights of any participant provided that an Offering Period may be terminated by the Board on an Exercise Date or by the
Board’s setting a new Exercise Date with respect to an Offering Period then in progress if the Board determines that termination of the Offering Period is in the best interests of the Company and the stockholders or if continuation of the
Offering Period would cause the Company to incur adverse accounting charges in the generally-accepted accounting rules applicable to the Plan. In addition, to the extent necessary to comply with Section 423 of the Code (or any successor rule or
provision or any applicable law or regulation), the Company shall obtain stockholder approval in such a manner and to such a degree as so required. 
 (b) Without stockholder consent and without regard to whether any participant rights may be considered to have been adversely affected, the Board shall be entitled to change the Offering Periods, limit
the frequency and/or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated
by a participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that
amounts applied toward the purchase of Common Stock for each participant properly correspond with amounts withheld from the participant’s Compensation, and establish such other limitations or procedures as the Board determines in its sole
discretion advisable that are consistent with the Plan. 
 20. Notices. All notices or other communications by a
participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.

 21. Conditions Upon Issuance of Shares. Shares shall not be issued with respect to an option unless the exercise of
such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of
1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such
compliance. 
 As a condition to the exercise of an option, the Company may require the person exercising such option to
represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation
is required by any of the aforementioned applicable provisions of law. 
 22. Information Regarding Disqualifying
Dispositions. By electing to participate in the Plan, each participant agrees to provide any information about any transfer of shares of Common Stock acquired under the Plan that occurs within two years after the first business day of the
Offering Period in which such shares were acquired as may be requested by the Company or any Subsidiaries in order to assist it in complying with the tax laws. 

  
 7 

 23. Right to Terminate Employment. Nothing in the Plan or in any agreement entered
into pursuant to the Plan shall confer upon any Employee the right to continue in the employment of the Company or any Subsidiary, or affect any right which the Company or any Subsidiary may have to terminate the employment of such Employee.

 24. Rights as a Stockholder. Neither the granting of an option nor a deduction from payroll shall constitute an
Employee the owner of shares covered by an option. No Employee shall have any right as a stockholder unless and until an option has been exercised, and the shares underlying the option have been registered in the Company’s share register.

 25. Term of Plan. The Plan shall be effective upon the closing of the initial public offering of Common Stock and
shall continue in effect for a term of ten years unless sooner terminated under paragraph 19. 
 26. Applicable Law. This
Plan shall be governed in accordance with the laws of the State of Delaware, applied without giving effect to any conflict-of-law principles. 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]